INVA - Company ID 0001080014
The table below shows Innoviva, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | $97.99M | $107.80M | $100.28M | $88.63M | $89.51M | $99.90M |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | $75.83M | $75.54M | $83.15M | $73.31M | $73.01M | $84.99M |
| R&D | $5.24M | $13.67M | $7.98M | $4.40M | $3.55M | $2.56M |
Innoviva, Inc. reported annual revenue of $411.33M for fiscal year 2025. That is up 14.7% from $358.71M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $133.57M (FY 2016) to $411.33M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A |
| $32.44M |
| $27.29M |
| $26.41M |
| $27.49M |
| $26.22M |
| $27.74M |
| Operating income | $38.15M | $34.58M | $48.75M | $41.43M | $43.24M | $54.69M |
| Income tax | $47.97M | $7.91M | $8.91M | $8.00M | $5.64M | -$4.59M |
| Net income | - | - | - | - | - | - |
| EPS (diluted) | $2.22 | $1.08 | $0.77 | -$0.74 | $0.02 | -$0.55 |